PNPLA3 and metabolic dysfunction-associated steatohepatitis: Interleukin 32 (IL32) mRNA expression was increased in steatotic liver disease and MASH samples solely in PNPLA3 I148M (rs738409 CG/GG) variant carriers, not in non-carriers (CC) [29].